Nurexone Biologic Stock Market Value
| NRX Stock | 0.70 0.04 5.41% |
| Symbol | NurExone |
NurExone Biologic 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NurExone Biologic's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NurExone Biologic.
| 09/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in NurExone Biologic on September 29, 2024 and sell it all today you would earn a total of 0.00 from holding NurExone Biologic or generate 0.0% return on investment in NurExone Biologic over 60 days. NurExone Biologic is related to or competes with Data Communications, Hemisphere Energy, and CVW CleanTech. NurExone Biologic is entity of Canada. It is traded as Stock on V exchange. More
NurExone Biologic Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NurExone Biologic's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NurExone Biologic upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.43 | |||
| Information Ratio | 0.0346 | |||
| Maximum Drawdown | 26.21 | |||
| Value At Risk | (5.36) | |||
| Potential Upside | 8.47 |
NurExone Biologic Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NurExone Biologic's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NurExone Biologic's standard deviation. In reality, there are many statistical measures that can use NurExone Biologic historical prices to predict the future NurExone Biologic's volatility.| Risk Adjusted Performance | 0.0544 | |||
| Jensen Alpha | 0.4367 | |||
| Total Risk Alpha | (0.51) | |||
| Sortino Ratio | 0.04 | |||
| Treynor Ratio | (0.26) |
NurExone Biologic Backtested Returns
NurExone Biologic appears to be out of control, given 3 months investment horizon. NurExone Biologic has Sharpe Ratio of 0.083, which conveys that the firm had a 0.083% return per unit of risk over the last 3 months. We have found thirty technical indicators for NurExone Biologic, which you can use to evaluate the volatility of the firm. Please exercise NurExone Biologic's Downside Deviation of 4.43, mean deviation of 3.46, and Risk Adjusted Performance of 0.0544 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, NurExone Biologic holds a performance score of 6. The company secures a Beta (Market Risk) of -1.16, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning NurExone Biologic are expected to decrease by larger amounts. On the other hand, during market turmoil, NurExone Biologic is expected to outperform it. Please check NurExone Biologic's potential upside, as well as the relationship between the kurtosis and day typical price , to make a quick decision on whether NurExone Biologic's current price movements will revert.
Auto-correlation | 0.58 |
Modest predictability
NurExone Biologic has modest predictability. Overlapping area represents the amount of predictability between NurExone Biologic time series from 29th of September 2024 to 29th of October 2024 and 29th of October 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NurExone Biologic price movement. The serial correlation of 0.58 indicates that roughly 58.0% of current NurExone Biologic price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.58 | |
| Spearman Rank Test | 0.56 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
NurExone Biologic lagged returns against current returns
Autocorrelation, which is NurExone Biologic stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting NurExone Biologic's stock expected returns. We can calculate the autocorrelation of NurExone Biologic returns to help us make a trade decision. For example, suppose you find that NurExone Biologic has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
NurExone Biologic regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If NurExone Biologic stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if NurExone Biologic stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in NurExone Biologic stock over time.
Current vs Lagged Prices |
| Timeline |
NurExone Biologic Lagged Returns
When evaluating NurExone Biologic's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of NurExone Biologic stock have on its future price. NurExone Biologic autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, NurExone Biologic autocorrelation shows the relationship between NurExone Biologic stock current value and its past values and can show if there is a momentum factor associated with investing in NurExone Biologic.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NurExone Stock Analysis
When running NurExone Biologic's price analysis, check to measure NurExone Biologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NurExone Biologic is operating at the current time. Most of NurExone Biologic's value examination focuses on studying past and present price action to predict the probability of NurExone Biologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NurExone Biologic's price. Additionally, you may evaluate how the addition of NurExone Biologic to your portfolios can decrease your overall portfolio volatility.